The most comprehensive literature review of structural valve deterioration to date just took on this question. Although data were abundant, useful comparisons were few. The authors explain.
3 Things to Keep an Eye on in Evolving TAVR Care
The next waves of progress in transcatheter aortic valve replacement are likely to involve expanding indications, valve refinements and new accessory treatments.
Thoracic Aortic Aneurysm: How to Counsel, When to Refer
Key clinicians from our Aorta Center share guidance on care from referral to medical and surgical management to patient and family follow-up.
Taking the Cleveland Clinic Heart Care Model to London
When Cleveland Clinic opens a high-tech inpatient hospital in the heart of London in 2021, comprehensive cardiovascular care will be a key focus. Here’s the what, why and how behind this expansion.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
6 Reasons for 24 Years of Top-Ranking Cardiovascular Care
Our Heart & Vascular Institute Chair reflects on what’s always new about a top ranking from U.S. News & World Report — and the underlying factors that must remain constant.
CMS Should Consider Quality, Not Just Quantity, for TAVR Coverage
Our experts outline their vision of ideal changes to the National Coverage Determination for programs performing transcatheter aortic valve replacement. A CMS decision is due in June 2019.
Loeys-Dietz Syndrome: Prophylactic Aortic Surgery Brings Excellent Outcomes in This Connective Tissue Disorder
Despite its malignant prognosis, this connective tissue disorder marked by early aortic dissection is far from unmanageable. One of the largest series reported to date proves the point.
CME Symposia at ACC.18 Take on Aortic Disease and Integrated Heart Failure Care
Cleveland Clinic is offering two complimentary dinner symposia on the Friday evening of the ACC meeting in Orlando that can’t be beat for practical clinical value.
Aortic Valve Repair: Durability Demonstrated in Largest Series to Date
Just 1 in 10 aortic valve repair patients required reoperation within a decade, a large study shows. What does this mean for weighing repair as an alternative to replacement for selected patients?
New Aortic Bioprosthesis Designed for Durability Makes Its U.S. Debut
The Inspiris Resilia aortic bioprosthesis is officially launched, and Cleveland Clinic just performed some of its first U.S. commercial implantations. A COMMENCE trial investigator reflects on the device’s points of distinction.